BRAF and Papillary Craniopharyngioma: While empiric treatment in this unique case was effective, tissue diagnosis is still recommended for formal diagnosis and molecular and genetic analysis, as approximately 5% of papillary craniopharyngiomas have not demonstrated the BRAF V600E mutation, as described in the original genomic analysis [3].